1. Home
  2. GSAT vs CAI Comparison

GSAT vs CAI Comparison

Compare GSAT & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globalstar Inc.

GSAT

Globalstar Inc.

SELL

Current Price

$83.40

Market Cap

10.7B

ML Signal

SELL

Logo Caris Life Sciences Inc.

CAI

Caris Life Sciences Inc.

SELL

Current Price

$32.28

Market Cap

8.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GSAT
CAI
Founded
2003
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
8.6B
IPO Year
2006
2025

Fundamental Metrics

Financial Performance
Metric
GSAT
CAI
Price
$83.40
$32.28
Analyst Decision
Buy
Buy
Analyst Count
3
14
Target Price
★ $90.00
$31.62
AVG Volume (30 Days)
564.6K
★ 3.6M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 74.58
69.79
EPS
N/A
★ N/A
Revenue
$112,660,000.00
★ $812,033,000.00
Revenue This Year
$8.42
$26.78
Revenue Next Year
$20.04
$19.27
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 96.97
52 Week Low
$41.06
$14.19
52 Week High
$84.85
$33.13

Technical Indicators

Market Signals
Indicator
GSAT
CAI
Relative Strength Index (RSI) 56.61 62.94
Support Level $80.87 $16.52
Resistance Level $83.93 $32.73
Average True Range (ATR) 0.71 2.05
MACD -0.01 0.06
Stochastic Oscillator 79.59 93.31

Price Performance

Historical Comparison
GSAT
CAI

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services, including voice and data communications services to retail, business, and governmental customers, as well as wholesale satellite capacity services. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is the owner of satellite assets. It has one reportable segment: the MSS business. The company generates the vast majority of its revenue within the United States.

About CAI Caris Life Sciences Inc.

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Share on Social Networks: